VEYVONDI – Vonicog alfa uses, dose and side effects
VEYVONDI contains the active substance vonicog alfa, a recombinant human von Willebrand factor (rVWF). The drug behaves in the same way as natural human von Willebrand factor (VWF) in the body. VWF is a carrier molecule for coagulation factor VIII, and is involved in blood clotting, by making platelets stick to wounds so that the blood clots. Lack of VWF increases the tendency to bleed.
Read More